Top Links

Articles Related to colorectal cancer

Langerhans Cell Histiocytosis in a Patient with Lynch Syndrome (Hereditary Non Polyposis Colorectal Cancer)

A fifty three year old white female smoker with Lynch Syndrome was receiving adjuvant chemotherapy for node positive caecal adenocarcinoma. Interval investigations demonstrated a second primary gastric cancer with bilateral pulmonary nodules of indeterminate significance. Lung biopsy revealed Langerhans cell histiocytosis (LCH).
View complete article: PDF  |  Full-text

Phase II Trial of Lower Dose Bevacizumab and Irinotecan in Relapsed High Grade Gliomas

Relapsed high-grade gliomas (HGG) respond poorly to known chemotherapeutic agents with a median survival of 3 to 6 months. Several phase II trials of Bevacizumab for salvage therapy, reported excellent response rates. The optimal dose of Bevacizumab in GBM has not been defined to date. We performed a prospective phase II trial of bevacizumab using 5 mg/kg every 2 weeks.
View complete article: PDF  |  Full-text

Mucinous Adenocarcinoma of the Colon Mimicking an Abdominal Wall Cellulitis

Cutaneous metastases from abdominal malignancies are rare and have been reported in less than 5% of patients [1]. Furthermore, metastases in patients suffering from colorectal neoplasia are even rarer entity. Tan et al, among 2538 of the new cases of colorectal cancer over the period of 6 years, reported only 3 cases (0.1%) with cutaneous deposits [1]. Presentation varies from cutaneous or subcutaneous small nodules, rash or large fungating lesions [1-4]. Inevitably, their presence implies the disease progression, and poor prognosis with the reported survival between 1 to 34 months [2,3,5].
View complete article: PDF  |  Full-text


Editorial Board Members Related to colorectal cancer

Rajkumar Vajpeyi

Assistant Professor
Laboratory Medicine and Pathobiology
University of Toronto
Canada

PAUL G HORGAN

Professor
Department of Surgery
University of Glasgow
United Kingdom

KELLI BULLARD DUNN

Professor
Department of Surgery
Roswell Park Cancer Institute
University of Louisville School of Medicine
United States

YARON NIV

Clinical Professor of Medicine
Tel-Aviv University
Israel
Submit Manuscript